Baltimore -- The immunosuppressant agent mycophenolate mofetil (CellCept) should be considered the steroid-sparing drug of choice in the management of pemphigus, according to Daniel Mimouni, M.D.
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
The Weekly Roundup: September 18-22
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children
Combination Treatments in HS Require Further Review